Caffeinated Coffee and Tea Lower Dementia Risk; Decaf Shows No Benefit

Patients frequently ask whether their daily coffee or tea habits will protect their aging brains, but the epidemiological evidence has historically offered mixed answers. Several meta-analyses suggest that moderate coffee and tea consumption may reduce the risk of cognitive deficits, Alzheimer disease, and vascular dementia, with one review of 38 cohorts encompassing 751,824 participants showing that drinking one to three cups of coffee daily reduces overall dementia risk [1, 2, 3]. However, data regarding the optimal daily intake remain conflicting, as dose-response analyses indicate a J-shaped or U-shaped curve where consuming three or more cups of coffee per day might actually increase the risk of all-cause dementia [4, 5]. Furthermore, previous research has often failed to isolate the effects of caffeine from other phytochemicals (biologically active plant compounds) by comparing caffeinated and decaffeinated beverages directly. A newly published cohort study tracking 131,821 participants over a median of 36.8 years now clarifies this relationship, demonstrating that the highest quartile of caffeinated coffee intake significantly lowers incident dementia risk (hazard ratio 0.82, 95% confidence interval 0.76 to 0.89) compared to the lowest quartile, offering precise clinical parameters for counseling patients on long-term cognitive preservation [6].